Video Shorts

1:06
Market Watch Rx: Cigna Joins Top Gainers
5 days ago
by
Nicholas Jacobus

1:13
Solving the Healthcare Cost Crisis Through Collective Action
6 days ago
by
Mike Hollan(+1 more)

1:06
Market Watch Rx: Editas Medicine Leads Gainers
12 days ago
by
Nicholas Jacobus

0:46
The First Amendment's Impact on DTC Prescription Drug Ads
13 days ago
by
Mike Hollan(+1 more)

0:38
Improving FDA & Biopharma's Relationship
13 days ago
by
Nicholas Jacobus(+1 more)

0:59
Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets
16 days ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: Baxter International Leads Gainers
19 days ago
by
Nicholas Jacobus

0:43
FDA's Shift: Why Predictability Now Matters More Than Speed
20 days ago
by
Mike Hollan(+1 more)

0:45
Using Data to Come to the Right Conclusions
21 days ago
by
Mike Hollan(+1 more)

1:12
Market Watch Rx: Humana Leads Top Gainers
a month ago
by
Nicholas Jacobus

0:53
FDA Leadership Turnover Explained
a month ago
by
Mike Hollan(+1 more)

1:19
Market Watch Rx: Eli Lilly Joins Top Gainers
a month ago
by
Nicholas Jacobus

0:49
Why the US Healthcare System is Fragmented
a month ago
by
Mike Hollan(+1 more)

0:32
Why Patient Care is the Heart of Pharma Business
a month ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: West Pharmaceutical Services Leads Gainers
a month ago
by
Nicholas Jacobus

0:32
Why 'Just-In-Time' Delivery is a Trap
a month ago
by
Nicholas Jacobus(+1 more)

0:29
The United State's Regulatory Impact on Global Drug Launches
a month ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
2 months ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
2 months ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
2 months ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
2 months ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
2 months ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
2 months ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
2 months ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
2 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
2 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
3 months ago
by
Michael Christel(+2 more)
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5

